4186 Stock Overview
Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Taiwan Advance Bio-Pharmaceutical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$15.55 |
| 52 Week High | NT$20.90 |
| 52 Week Low | NT$14.00 |
| Beta | 0.85 |
| 11 Month Change | 1.63% |
| 3 Month Change | -9.06% |
| 1 Year Change | -9.06% |
| 33 Year Change | -17.72% |
| 5 Year Change | -18.37% |
| Change since IPO | -79.13% |
Recent News & Updates
Shareholder Returns
| 4186 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -0.3% | -2.5% | -0.5% |
| 1Y | -9.1% | 0.7% | 28.4% |
Return vs Industry: 4186 underperformed the TW Biotechs industry which returned 0.7% over the past year.
Return vs Market: 4186 underperformed the TW Market which returned 28.4% over the past year.
Price Volatility
| 4186 volatility | |
|---|---|
| 4186 Average Weekly Movement | 4.8% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.1% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4186 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4186's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 154 | n/a | www.biotest.com.tw |
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse.
Taiwan Advance Bio-Pharmaceutical Inc. Fundamentals Summary
| 4186 fundamental statistics | |
|---|---|
| Market cap | NT$1.41b |
| Earnings (TTM) | NT$21.41m |
| Revenue (TTM) | NT$338.83m |
65.4x
P/E Ratio4.1x
P/S RatioIs 4186 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4186 income statement (TTM) | |
|---|---|
| Revenue | NT$338.83m |
| Cost of Revenue | NT$109.66m |
| Gross Profit | NT$229.17m |
| Other Expenses | NT$207.77m |
| Earnings | NT$21.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 67.64% |
| Net Profit Margin | 6.32% |
| Debt/Equity Ratio | 122.0% |
How did 4186 perform over the long term?
See historical performance and comparison